🔥 42 IAS Prelims 2026 Questions Themes Came Directly from Our Expected Topics. Click for the Proof. 🔥 Admissions Open for 21st November GS Batch. Register Now. 🔥 Heartiest Congratulations to all UPSC CSE Mains 2026 qualifiers! 31+ students from RICE IAS have successfully cleared the Mains examination.

Retatrutide: A Novel Drug for Obesity and Osteoarthritis

Context

An experimental drug, retatrutide, has demonstrated significant reduction in knee pain among people with obesity and osteoarthritis during clinical trials, highlighting the potential of multi-hormonal therapies in obesity management and the treatment of obesity-related complications.

Obesity and Orthopaedic Health

  • Obesity: A condition characterised by excessive accumulation of body fat that poses risks to health and increases mechanical stress on the musculoskeletal system.
  • Osteoarthritis: A degenerative joint disease involving cartilage breakdown and changes in underlying bone, commonly affecting knees, hips and hands.
  • Association: Obesity increases the risk of osteoarthritis, particularly in weight-bearing joints, contributing to joint degeneration, pain and reduced mobility.
  • Management: Weight reduction can decrease mechanical stress on joints, alleviate osteoarthritis-related pain and improve mobility.

Existing Treatment Approaches

  • Lifestyle Modification: Diet control, exercise and weight management.
  • Pharmacological Treatment: Non-steroidal anti-inflammatory drugs (NSAIDs) and corticosteroid injections for pain management.
  • Physical Therapy: Exercises to improve joint mobility, flexibility and muscle strength.
  • Other Treatments: Topical medications and, in advanced cases, joint replacement surgery.

Mechanism of Action

HormoneMajor Functions
GLP-1Stimulates insulin secretion, suppresses glucagon secretion and promotes satiety.
GIPStimulates glucose-dependent insulin secretion and regulates metabolism.
GlucagonIncreases blood glucose levels and influences energy expenditure.

Key Findings of the Clinical Trials

  • Study Design: Two Phase 3 clinical trials involving adults with painful knee osteoarthritis, BMI of at least 27 and no diabetes.
  • Pain Reduction: Approximately two-thirds of participants receiving retatrutide experienced at least a 50% reduction in knee pain, compared with 38% receiving placebo.
  • Potential Benefit: Weight reduction may decrease mechanical stress on knee joints and improve mobility in people with obesity.
Important CTC from this article:

GLP-1
                                                    MCQ



With respect to Retatrutide, consider the following statements:

I. It is a triple hormone receptor agonist that simultaneously targets GLP-1, GIP, and glucagon receptors.
II. Activation of the glucagon receptor by this molecule helps enhance energy expenditure and lipid metabolism.
III. It is an oral monoclonal antibody approved for the treatment of Type 1 diabetes.

Which of the statements given above are correct?

(a) I and II only
(b) II and III only
(c) I and III only
(d) I, II and III

Answer: (a) I and II only

Explanation:
• Statement I is correct:
Retatrutide is an investigational triple hormone receptor agonist (often termed a "triple-G" drug) that mimics three metabolic hormones—Glucagon-like peptide-1 (GLP-1), Glucose-dependent insulinotropic polypeptide (GIP), and glucagon—to regulate blood glucose and appetite.
• Statement II is correct: While GLP-1 and GIP receptor activation primarily stimulates glucose-dependent insulin secretion and suppresses appetite, the addition of glucagon receptor (GCGR) activation promotes energy expenditure and lipid oxidation (fat burning) in the liver and adipose tissue.
• Statement III is incorrect: Retatrutide is an investigational synthetic peptide (not a monoclonal antibody) administered via injection, being developed primarily for obesity and Type 2 diabetes, and it has not yet received final regulatory approval.



PYQ (2019)


Which of the following are the reasons for the occurrence of multi-drug resistance in microbial pathogens in India?

1. Genetic predisposition of some people
2. Taking incorrect doses of antibiotics to cure diseases
3. Using antibiotics in livestock farming
4. Multiple chronic diseases in some people

Select the correct answer using the code given below.

A. 1 and 2
B. 2 and 3 only
C. 1, 3 and 4
D. 2, 3 and 4